natgillin/translations-raw huggingface dataset:
in the case of a product containing sedaxane as the only active substance, where necessary, amend or withdraw the authorisation by 31 July 2015 at the latest; or
če sredstvo vsebuje sedaksan kot edino aktivno snov, po potrebi spremenijo ali prekličejo registracijo najpozneje do 31. julija 2015; ali
in the case of a product containing sedaxane as one of several active substances, where necessary, amend or withdraw the authorisation by 31 July 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
če sredstvo vsebuje sedaksan kot eno od več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 31. julija 2015 ali do datuma, določenega za tako spremembo ali preklic v ustreznih aktih, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS oziroma s katerimi so bile zadevne snovi odobrene, pri čemer se upošteva poznejši datum.
CAS No 874967-67-6
št. CAS 874967-67-6
(trans isomer: 599197-38-3/cis isomer: 599194-51-1)
(trans-izomer: 599197-38-3 / cis-izomer: 599194-51-1)
CIPAC No 833
št. CIPAC 833
mixture of 2 cis-isomers 2′-[(1RS,2RS)-1,1′-bicycloprop-2-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxanilide and 2 trans-isomers 2′-[(1RS,2SR)-1,1′-bicycloprop-2-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxanilide
mešanica 2 cis-izomerov 2′-[(1RS,2RS)-1,1′-bicycloprop-2-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxanilide in 2 trans-izomerov 2′-[(1RS,2SR)-1,1′-bicycloprop-2-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxanilide
≥ 960 g/kg Sedaxane
≥ 960 g/kg sedaksana
(range 820-890 g/kg for the 2 trans-isomers 50:50 mixture of enantiomers and range 100-150 g/kg for the 2 cis-isomers 50:50 mixture of enantiomers)
(razpon 820–890 g/kg za 2 trans-izomera v razmerju 50: 50 v mešanici enantiomerov in razpon 100–150 g/kg za 2 cis-izomera v razmerju 50: 50 v mešanici enantiomerov)
Only uses for seed treatment may be authorised.
Registrira se lahko samo za tretiranje semen.
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on sedaxane, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 16 July 2013 shall be taken into account.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu sedaksana ter zlasti dodatka I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 16. julija 2013.
the long-term risk to birds and mammals.
dolgoročno tveganje za ptice in sesalce.
Conditions of authorisation shall include risk mitigation measures, where appropriate.
Pogoji uporabe po potrebi vključujejo ukrepe za zmanjšanje tveganja.
The Member States concerned shall carry out monitoring programmes to verify potential groundwater contamination from the metabolite CSCD465008 in vulnerable zones, where appropriate.
Zadevne države članice po potrebi izvajajo programe spremljanja za potrditev morebitne onesnaženosti podtalnice z metabolitom CSCD465008 na občutljivih območjih.
The Member States concerned shall request the submission of confirmatory information as regards the relevance of the metabolite CSCD465008, and the corresponding groundwater risk assessment, if sedaxane is classified under Regulation (EC) No 1272/2008 as ‘suspected of causing cancer’.
Zadevne države članice zahtevajo predložitev potrditvenih informacij o pomenu metabolita CSCD465008 ter ustrezne ocene tveganja za podtalnico, če je sedaksan v skladu z Uredbo (ES) št. 1272/2008 razvrščen v kategorijo ‚sum povzročitve raka‘.
The notifier shall submit to the Commission, the Member States and the Authority the relevant information within six months from the application date of the Regulation classifying sedaxane.
Prijavitelj Komisiji, državam članicam in Agenciji predloži ustrezne informacije v šestih mesecih od datuma začetka uporabe uredbe o razvrstitvi sedaksana.
The notifier shall submit to the Commission, the Member States and the Authority the relevant information within six months from the application date of the Regulation classifying sedaxane.’
Prijavitelj Komisiji, državam članicam in Agenciji predloži ustrezne informacije v šestih mesecih od datuma začetka uporabe uredbe o razvrstitvi sedaksana.“
For sedaxane the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2011/123/EU [3].
S Sklepom Komisije 2011/123/EU [3] je bilo potrjeno, da sedaksan izpolnjuje pogoje iz člena 80(1)(a) Uredbe (ES) št. 1107/2009.
Commission Implementing Regulation (EU) No 827/2013
Izvedbena uredba Komisije (EU) št. 827/2013
approving the active substance Aureobasidium pullulans (strains DSM 14940 and DSM 14941), in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobritvi aktivne snovi Aureobasidium pullulans (seva DSM 14940 in DSM 14941) v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet in spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
In accordance with Article 6(2) of Directive 91/414/EEC Austria received on 17 April 2008 an application from bio-ferm Biotechnologische Entwicklung und Produktion GmbH for the inclusion of the active substance Aureobasidium pullulans (strains DSM 14940 and DSM 14941) in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Avstrija 17. aprila 2008 prejela zahtevek biofarme Biotechnologische Entwicklung und Produktion GmbH za vključitev aktivne snovi Aureobasidium pullulans (seva DSM 14940 in DSM 14941) v Prilogo I k Direktivi 91/414/EGS.
Decision 2008/953/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo 2008/953/ES je bilo potrjeno, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
The designated rapporteur Member State submitted a draft assessment report on 17 December 2009.
Država članica poročevalka je 17. decembra 2009 predložila osnutek poročila o oceni.
In accordance with Article 11(6) of Commission Regulation (EU) No 188/2011 [4] additional information was requested from the applicant on 26 July 2011.
V skladu s členom 11(6) Uredbe Komisije (EU) št. 188/2011 [4] so se od vlagatelja 26. julija 2011 zahtevale dodatne informacije.
The evaluation of the additional data by Austria was submitted in the format of an updated draft assessment report in January 2012.
Avstrija je januarja 2012 oceno dodatnih podatkov predložila v obliki posodobljenega osnutka poročila o oceni.
The Authority presented to the Commission its conclusion [5] on the review of the pesticide risk assessment of the active substance Aureobasidium pullulans (strains DSM 14940 and DSM 14941) on 2 April 2013.
Agencija je 2. aprila 2013 Komisiji predložila sklep [5] o pregledu ocene tveganja pesticidov z aktivno snovjo Aureobasidium pullulans (seva DSM 14940 in DSM 14941).
The draft assessment report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 16 July 2013 in the format of the Commission review report for Aureobasidium pullulans (strains DSM 14940 and DSM 14941).
Osnutek poročila o oceni in sklep Agencije so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 16. julija 2013 v obliki poročila Komisije o pregledu Aureobasidium pullulans (seva DSM 14940 in DSM 14941).
It has appeared from the various examinations made that plant protection products containing Aureobasidium pullulans (strains DSM 14940 and DSM 14941) may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo Aureobasidium pullulans (seva DSM 14940 in DSM 14941), lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) ter člena 5(3) Direktive 91/414/EGS, zlasti pri uporabah, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to approve Aureobasidium pullulans (strains DSM 14940 and DSM 14941).
Zato je primerno, da se Aureobasidium pullulans (seva DSM 14940 in DSM 14941) odobri.
Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing Aureobasidium pullulans (strains DSM 14940 and DSM 14941).
Državam članicam bi bilo treba omogočiti, da v šestih mesecih po odobritvi pregledajo registracije fitofarmacevtskih sredstev, ki vsebujejo Aureobasidium pullulans (seva DSM 14940 in DSM 14941).
The experience gained from inclusions in Annex I to Directive 91/414/EEC of active substances assessed in the framework of Commission Regulation (EEC) No 3600/92 [6] has shown that difficulties can arise in interpreting the duties of holders of existing authorisations in relation to access to data.
Izkušnje iz prejšnjih vključitev aktivnih snovi, ocenjenih na podlagi Uredbe Komisije (EGS) št. 3600/92 [6], v Prilogo I k Direktivi 91/414/EGS so pokazale, da lahko pride do težav pri razlagi dolžnosti imetnikov obstoječih registracij v zvezi z dostopom do podatkov.
In accordance with Article 13(4) of Regulation (EC) No 1107/2009, the Annex to Commission Implementing Regulation (EU) No 540/2011 [7] should be amended accordingly.
V skladu s členom 13(4) Uredbe (ES) št. 1107/2009 bi bilo treba ustrezno spremeniti Prilogo k Izvedbeni uredbi Komisije (EU) št. 540/2011 [7].
The active substance Aureobasidium pullulans (strains DSM 14940 and DSM 14941), as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov Aureobasidium pullulans (seva DSM 14940 in DSM 14941), kot je opredeljena v Prilogi I, se odobri v skladu s pogoji iz navedene priloge.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing Aureobasidium pullulans (strains DSM 14940 and DSM 14941) as an active substance by 31 July 2014.
Države članice v skladu z Uredbo (ES) št. 1107/2009 do 31. julija 2014 po potrebi spremenijo ali prekličejo veljavne registracije fitofarmacevtskih sredstev, ki vsebujejo Aureobasidium pullulans (seva DSM 14940 in DSM 14941) kot aktivno snov.
By way of derogation from paragraph 1, for each authorised plant protection product containing Aureobasidium pullulans (strains DSM 14940 and DSM 14941) as either the only active substance or as one of several active substances, all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 31 January 2014 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account the column on specific provisions of Annex I to this Regulation.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje Aureobasidium pullulans (seva DSM 14940 in DSM 14941) kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo k Izvedbeni uredbi (EU) št. 540/2011 najpozneje do 31. januarja 2014, po enotnih načelih iz člena 29(6) Uredbe (ES) št. 1107/2009, na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k Direktivi 91/414/EGS, in ob upoštevanju stolpca o posebnih določbah iz Priloge I k tej uredbi.
in the case of a product containing Aureobasidium pullulans (strains DSM 14940 and DSM 14941) as the only active substance, where necessary, amend or withdraw the authorisation by 31 July 2015 at the latest; or
če sredstvo vsebuje Aureobasidium pullulans (seva DSM 14940 in DSM 14941) kot edino aktivno snov, po potrebi spremenijo ali prekličejo registracijo najpozneje do 31. julija 2015, ali
in the case of a product containing Aureobasidium pullulans (strains DSM 14940 and DSM 14941) as one of several active substances, where necessary, amend or withdraw the authorisation by 31 July 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
če sredstvo vsebuje Aureobasidium pullulans (seva DSM 14940 in DSM 14941) kot eno od več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 31. julija 2015 ali do datuma, določenega za tako spremembo ali preklic v ustreznih aktih, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS oziroma s katerimi so bile zadevne snovi odobrene, pri čemer se upošteva poznejši datum.
Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230, 19.8.1991, p. 1)
Direktiva Sveta 91/414/EGS z dne 15. julija 1991 o dajanju fitofarmacevtskih sredstev v promet (UL L 230, 19.8.1991, str. 1).
Commission Decision 2008/953/EC of 8 December 2008 recognising in principle the completeness of the dossiers submitted for detailed examination in view of the possible inclusion of Aureobasidium pullulans and disodium phosphonate in Annex I to Council Directive 91/414/EEC (OJ L 338, 17.12.2008, p. 62)
Odločba Komisije 2008/953/ES z dne 8. decembra 2008 o načelnem priznavanju popolnosti dokumentacij, predloženih v podrobno oceno zaradi možne vključitve Aureobasidium pullulans in dinatrijevega fosfonata v Prilogo I k Direktivi Sveta 91/414/EGS (UL L 338, 17.12.2008, str. 62).
Commission Regulation (EU) No 188/2011 of 25 February 2011 laying down detailed rules for the implementation of Council Directive 91/414/EEC as regards the procedure for the assessment of active substances which were not on the market 2 years after the date of notification of that Directive (OJ L 53, 26.2.2011, p. 51).
Uredba Komisije (EU) št. 188/2011 z dne 25. februarja 2011 o podrobnih pravilih za izvajanje Direktive Sveta 91/414/EGS glede postopka za oceno aktivnih snovi, ki niso bile v prometu dve leti po dnevu notifikacije navedene direktive (UL L 53, 26.2.2011, str. 51).
Aureobasidium pullulans (strains DSM 14940 and DSM 14941)
Aureobasidium pullulans (seva DSM 14940 in DSM 14941)
Collection number: German Collection of Microorganisms and cell Cultures (DSMZ) with the accession numbers DSM 14940 and DSM 14941
Številka zbirke: nemška zbirka mikroorganizmov in celičnih kultur (DSMZ) z referenčnima številkama DSM 14940 in DSM 14941
Minimum 5,0 × 109 CFU/g for each strain;
najmanj 5,0 × 109 CFU/g za vsak sev;
Maximum 5,0 × 1010 CFU/g for each strain
največ 5,0 × 1010 CFU/g za vsak sev
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Aureobasidium pullulans (strains DSM 14940 and DSM 14941), and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 16 July 2013 shall be taken into account.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu Aureobasidium pullulans (seva DSM 14940 in DSM 14941) in zlasti dodatka I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 16. julija 2013.
In this overall assessment Member States shall pay particular attention to the protection of operators and workers, taking into account that Aureobasidium pullulans (strains DSM 14940 and DSM 14941) is to be considered as a potential sensitizer.
V tej celoviti oceni so države članice zlasti pozorne na zaščito izvajalcev in delavcev, ob upoštevanju, da lahko Aureobasidium pullulans (seva DSM 14940 in DSM 14941) povzroča preobčutljivost.
For Aureobasidium pullulans (strains DSM 14940 and DSM 14941) the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2008/953/EC [3].
Z Odločbo Komisije 2008/953/ES [3] je bilo potrjeno, da Aureobasidium pullulans (seva DSM 14940 in DSM 14941) izpolnjuje pogoje iz člena 80(1)(a) Uredbe (ES) št. 1107/2009.
Commission Implementing Regulation (EU) No 828/2013
Izvedbena uredba Komisije (EU) št. 828/2013
approving the active substance emamectin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobritvi aktivne snovi emamektin v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet ter o spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
In accordance with Article 6(2) of Directive 91/414/EEC the Netherlands received on 23 June 2006 an application from Syngenta Crop Protection AG for the inclusion of the active substance emamectin in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska 23. junija 2006 prejela zahtevek družbe Syngenta Crop Protection AG za vključitev aktivne snovi emamektin v Prilogo I k Direktivi 91/414/EGS.
Decision 2007/669/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
S Sklepom 2007/669/ES je bilo potrjeno, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
The designated rapporteur Member State submitted a draft assessment report on 6 March 2008.
Država članica poročevalka je 6. marca 2008 predložila osnutek poročila o oceni.
The Authority presented to the Commission its conclusion [4] on the pesticide risk assessment of the active substance emamectin on 13 November 2012.
Agencija je 13. novembra 2012 Komisiji predložila sklep o pregledu ocene tveganja pesticidov z aktivno snovjo emamektin [4].
The draft assessment report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 16 July 2013 in the format of the Commission review report for emamectin.
Osnutek poročila o oceni in sklep Agencije so države članice in Komisija pregledale v Stalnem odboru za prehranjevalno verigo in zdravje živali ter končno različico osnutka poročila o oceni pripravile 16. julija 2013 v obliki poročila Komisije o pregledu emamektina.
It has appeared from the various examinations made that plant protection products containing emamectin may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo emamektin, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) ter člena 5(3) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to approve emamectin.
Zato je primerno, da se emamektin odobri.
Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing emamectin.
Državam članicam bi bilo treba po odobritvi omogočiti šestmesečno obdobje, da pregledajo registracije fitofarmacevtskih sredstev, ki vsebujejo emamektin.
The active substance emamectin, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov emamektin, kot je opredeljena v Prilogi I, se odobri v skladu s pogoji iz navedene priloge.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing emamectin as an active substance by 31 October 2014.
Države članice v skladu z Uredbo (ES) št. 1107/2009 do 31. oktobra 2014 po potrebi spremenijo ali prekličejo veljavne registracije fitofarmacevtskih sredstev, ki vsebujejo emamektin kot aktivno snov.
By way of derogation from paragraph 1, for each authorised plant protection product containing emamectin as either the only active substance or as one of several active substances, all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 30 April 2014 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account the column on specific provisions of Annex I to this Regulation.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje emamektin kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo k Izvedbeni uredbi (EU) št. 540/2011 najpozneje do 30. aprila 2014, po enotnih načelih iz člena 29(6) Uredbe (ES) št. 1107/2009, na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k Direktivi 91/414/EGS, in ob upoštevanju stolpca o posebnih določbah iz Priloge I k tej uredbi.
in the case of a product containing emamectin as the only active substance, where necessary, amend or withdraw the authorisation by 31 October 2015 at the latest; or
če sredstvo vsebuje emamektin kot edino aktivno snov, po potrebi spremenijo ali prekličejo registracijo najpozneje do 31. oktobra 2015; ali
in the case of a product containing emamectin as one of several active substances, where necessary, amend or withdraw the authorisation by 31 October 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
če sredstvo vsebuje emamektin kot eno od več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 31. oktobra 2015 ali do datuma, določenega za tako spremembo ali preklic v ustreznih aktih, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS oziroma s katerimi so bile zadevne snovi odobrene, pri čemer se upošteva poznejši datum.
It shall apply from 1 May 2014.
Uporablja se od 1. maja 2014.
Emamectin
emamektin
(formerly 137335-79-6) and 123997-28-4
(prej 137335-79-6) in 123997-28-4
(formerly 137512-74-4 and 179607-18-2)
(prej 137512-74-4 in 179607-18-2)
Emamectin B1a:
emamektin B1a:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside
Emamectin B1b:
emamektin B1b:
Emamectin B1a benzoate:
emamektin B1a benzoat: